Correlation Between Travere Therapeutics and Vaxxinity
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Vaxxinity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Vaxxinity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Vaxxinity, you can compare the effects of market volatilities on Travere Therapeutics and Vaxxinity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Vaxxinity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Vaxxinity.
Diversification Opportunities for Travere Therapeutics and Vaxxinity
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Travere and Vaxxinity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Vaxxinity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxxinity and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Vaxxinity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxxinity has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Vaxxinity go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Vaxxinity
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 1.86 times less return on investment than Vaxxinity. But when comparing it to its historical volatility, Travere Therapeutics is 1.14 times less risky than Vaxxinity. It trades about 0.02 of its potential returns per unit of risk. Vaxxinity is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 250.00 in Vaxxinity on November 2, 2024 and sell it today you would earn a total of 22.00 from holding Vaxxinity or generate 8.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.47% |
| Values | Daily Returns |
Travere Therapeutics vs. Vaxxinity
Performance |
| Timeline |
| Travere Therapeutics |
| Vaxxinity |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Travere Therapeutics and Vaxxinity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Vaxxinity
The main advantage of trading using opposite Travere Therapeutics and Vaxxinity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Vaxxinity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxxinity will offset losses from the drop in Vaxxinity's long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| Vaxxinity vs. Tarsus Pharmaceuticals | Vaxxinity vs. Aldeyra | Vaxxinity vs. Travere Therapeutics | Vaxxinity vs. Eton Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |